-
1
-
-
33845241195
-
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
-
on behalf of the TASC II Working Group doi: 10.1016/j.ejvs.2006.09.024
-
Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR on behalf of the TASC II Working Group (2007) Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 33:S1-S75. doi: 10.1016/j.ejvs.2006.09.024
-
(2007)
Eur J Vasc Endovasc Surg
, vol.33
-
-
Norgren, L.1
Hiatt, W.R.2
Dormandy, J.A.3
Nehler, M.R.4
Harris, K.A.5
Fowkes, F.G.R.6
-
2
-
-
4644319949
-
Antithrombotic therapy in peripheral arterial occlusive disease. The seventh ACCP conference on antithrombotic and thrombolytic therapy
-
doi: 10.1378/chest.126.3_suppl.609S
-
Clagett GP, Sobel M, Jackson MR, Lip GYH, Angelder M, Verhaeghe R (2004) Antithrombotic therapy in peripheral arterial occlusive disease. The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126:609S-626S. doi: 10.1378/chest.126.3_suppl.609S
-
(2004)
Chest
, vol.126
-
-
Clagett, G.P.1
Sobel, M.2
Jackson, M.R.3
Lip, G.Y.H.4
Angelder, M.5
Verhaeghe, R.6
-
3
-
-
0037065502
-
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
-
Antithrombotic Trialist's Collaboration doi: 10.1136/bmj.324.7336.S71
-
Antithrombotic Trialist's Collaboration (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324:71-86. doi: 10.1136/bmj.324.7336.S71
-
(2002)
BMJ
, vol.324
, pp. 71-86
-
-
-
4
-
-
0026763834
-
Low-dose aspirin and subsequent peripheral arterial surgery in the Physicians' Health Study
-
doi: 10.1016/0140-6736(92)93216-A
-
Goldhaber SZ, Manson JE, Stampfer MJ, LaMotte F, Rosner B, Buring JE, Hennekens CH (1992) Low-dose aspirin and subsequent peripheral arterial surgery in the Physicians' Health Study. Lancet 340:143-145. doi: 10.1016/0140-6736(92)93216-A
-
(1992)
Lancet
, vol.340
, pp. 143-145
-
-
Goldhaber, S.Z.1
Manson, J.E.2
Stampfer, M.J.3
LaMotte, F.4
Rosner, B.5
Buring, J.E.6
Hennekens, C.H.7
-
5
-
-
0033561482
-
Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes
-
doi: 10.1016/S0002-9149(99)00049-1
-
Alexander JH, Harrington RA, Tuttle RH, Berdan LD, Linchoff AM, Deckers JW, Simoons ML, Guerci A, Hochman JS, Wilcox RG, Kitt MM, Eisenberg PR, Califf RM, Topol EJ, Karsh K, Ruzyllo W, Stepinska J, Widimsky P, Boland JB, Armstrong PW (1999) Prior aspirin use predicts worse outcomes in patients with non-ST-elevation acute coronary syndromes. Am J Cardiol 83:1147-1151. doi: 10.1016/S0002-9149(99)00049-1
-
(1999)
Am J Cardiol
, vol.83
, pp. 1147-1151
-
-
Alexander, J.H.1
Harrington, R.A.2
Tuttle, R.H.3
Berdan, L.D.4
Linchoff, A.M.5
Deckers, J.W.6
Simoons, M.L.7
Guerci, A.8
Hochman, J.S.9
Wilcox, R.G.10
Kitt, M.M.11
Eisenberg, P.R.12
Califf, R.M.13
Topol, E.J.14
Karsh, K.15
Ruzyllo, W.16
Stepinska, J.17
Widimsky, P.18
Boland, J.B.19
Armstrong, P.W.20
more..
-
6
-
-
8344231455
-
Aspirin and clopidogrel: Efficacy, safety, and the issue of drug resistance
-
doi: 10.1161/01.ATV.0000145980.39477.a9
-
Cattaneo M (2004) Aspirin and clopidogrel: Efficacy, safety, and the issue of drug resistance. Arterioscler Thromb Vasc Biol 24:1980-1987. doi: 10.1161/01.ATV.0000145980.39477.a9
-
(2004)
Arterioscler Thromb Vasc Biol
, vol.24
, pp. 1980-1987
-
-
Cattaneo, M.1
-
7
-
-
24944474901
-
Aspirin resistance: Position paper of the Working Group on Aspirin Resistance
-
doi: 10.1111/j.1538-7836.2005.01351.x
-
Michelson AD, Cattaneo M, Eikelboom JW, Gurbel P, Kottke-Marchant K, Kunicki TJ, Pulcinelli FM, Cerletti C, Rao AK (2005) Aspirin resistance: position paper of the Working Group on Aspirin Resistance. J Thromb Haemost 3:1309-1311. doi: 10.1111/j.1538-7836.2005.01351.x
-
(2005)
J Thromb Haemost
, vol.3
, pp. 1309-1311
-
-
Michelson, A.D.1
Cattaneo, M.2
Eikelboom, J.W.3
Gurbel, P.4
Kottke-Marchant, K.5
Kunicki, T.J.6
Pulcinelli, F.M.7
Cerletti, C.8
Rao, A.K.9
-
8
-
-
34249939815
-
Measuring antiplatelet drug effects in the laboratory
-
doi: 10.1016/j.thromres.2006.11.012
-
Harrison P, Frelinger AL, Furman MI, Michelson AD (2007) Measuring antiplatelet drug effects in the laboratory. Thromb Res 120:323-336. doi: 10.1016/j.thromres.2006.11.012
-
(2007)
Thromb Res
, vol.120
, pp. 323-336
-
-
Harrison, P.1
Frelinger, A.L.2
Furman, M.I.3
Michelson, A.D.4
-
9
-
-
40949119392
-
Standardization of light transmittance aggregometry for monitoring antiplatelet therapy: An adjustment for platelet count is not necessary
-
doi: 10.1111/j.1538-7836.2008.02891.x
-
Linnemann B, Schwonberg J, Mani H, Prochnow S, Lindhoff-Last E (2008) Standardization of light transmittance aggregometry for monitoring antiplatelet therapy: An adjustment for platelet count is not necessary. J Thromb Haemost 6:677-683. doi: 10.1111/j.1538-7836.2008.02891.x
-
(2008)
J Thromb Haemost
, vol.6
, pp. 677-683
-
-
Linnemann, B.1
Schwonberg, J.2
Mani, H.3
Prochnow, S.4
Lindhoff-Last, E.5
-
10
-
-
0035421783
-
Profile and prevalence of aspirin resistance in patients with cardiovascular disease
-
doi: 10.1016/S0002-9149(01)01631-9
-
Gum PA, Kottke-Marchant K, Poggio ED, Gurm H, Welsh PA, Brooks L, Sapp SK, Topol EJ (2001) Profile and prevalence of aspirin resistance in patients with cardiovascular disease. Am J Cardiol 88:230-235. doi: 10.1016/S0002-9149(01)01631-9
-
(2001)
Am J Cardiol
, vol.88
, pp. 230-235
-
-
Gum, P.A.1
Kottke-Marchant, K.2
Poggio, E.D.3
Gurm, H.4
Welsh, P.A.5
Brooks, L.6
Sapp, S.K.7
Topol, E.J.8
-
11
-
-
33846235920
-
Prevalence of persistent platelet reactivity despite use of aspirin: A systematic review
-
doi: 10.1016/j.ahj.2006.10.040
-
Hovens MM, Snoep JD, Eikenboom JC, van der Bom JG, Mertens BJ, Huisman MV (2007) Prevalence of persistent platelet reactivity despite use of aspirin: A systematic review. Am Heart J 153:175-181. doi: 10.1016/ j.ahj.2006.10.040
-
(2007)
Am Heart J
, vol.153
, pp. 175-181
-
-
Hovens, M.M.1
Snoep, J.D.2
Eikenboom, J.C.3
van der Bom, J.G.4
Mertens, B.J.5
Huisman, M.V.6
-
12
-
-
0034867946
-
Platelet function analyzer (PFA-100®): A tool to quantify congenital or acquired platelet dysfunction
-
doi: 10.1067/mlc.2001.117406
-
Jilma B (2001) Platelet function analyzer (PFA-100®): A tool to quantify congenital or acquired platelet dysfunction. J Lab Clin Med 138:152-163. doi: 10.1067/mlc.2001.117406
-
(2001)
J Lab Clin Med
, vol.138
, pp. 152-163
-
-
Jilma, B.1
-
13
-
-
0346433909
-
In vitro aspirin resistance detected by PFA-100 closure time: Pivotal role of von Willebrand factor
-
doi: 10.1046/j.1365-2141.2003.04727.x
-
Chakroun T, Gerotziafas G, Robert F, Lecrubier C, Samama MM, Hatmi M, Elalamy I (2004) In vitro aspirin resistance detected by PFA-100 closure time: Pivotal role of von Willebrand factor. Br J Haematol 124:80-85. doi: 10.1046/j.1365-2141.2003.04727.x
-
(2004)
Br J Haematol
, vol.124
, pp. 80-85
-
-
Chakroun, T.1
Gerotziafas, G.2
Robert, F.3
Lecrubier, C.4
Samama, M.M.5
Hatmi, M.6
Elalamy, I.7
-
14
-
-
33750967096
-
Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS
-
doi: 10.1111/j.1538-7836.2006.02239.x
-
Fuchs I, Frossard M, Spiel A, Riedmüller E, Laggner AN, Jilma B (2006) Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS. J Thromb Haemost 4:2547-2552. doi: 10.1111/ j.1538-7836.2006.02239.x
-
(2006)
J Thromb Haemost
, vol.4
, pp. 2547-2552
-
-
Fuchs, I.1
Frossard, M.2
Spiel, A.3
Riedmüller, E.4
Laggner, A.N.5
Jilma, B.6
-
15
-
-
18244392669
-
Screening for aspirin responsiveness after transient ischemic attack and stroke: Comparison of 2 point-of-care platelet function tests with optical aggregometry
-
doi: 10.1161/01.STR.0000162719.11058.bd
-
Harrison P, Segal H, Blasbery K, Furtado C, Silver L, Rothwell PM (2005) Screening for aspirin responsiveness after transient ischemic attack and stroke: Comparison of 2 point-of-care platelet function tests with optical aggregometry. Stroke 36:1001-1005. doi: 10.1161/ 01.STR.0000162719.11058.bd
-
(2005)
Stroke
, vol.36
, pp. 1001-1005
-
-
Harrison, P.1
Segal, H.2
Blasbery, K.3
Furtado, C.4
Silver, L.5
Rothwell, P.M.6
-
16
-
-
33644986263
-
Biological effects of aspirin and clopidogrel in a randomized cross-over study in 96 healthy volunteers
-
doi: 10.1111/j.1538-7836.2006.01867.x
-
Fontana P, Nolli S, Reber G, de Moerloose P (2006) Biological effects of aspirin and clopidogrel in a randomized cross-over study in 96 healthy volunteers. J Thromb Haemost 4:813-819. doi: 10.1111/ j.1538-7836.2006.01867.x
-
(2006)
J Thromb Haemost
, vol.4
, pp. 813-819
-
-
Fontana, P.1
Nolli, S.2
Reber, G.3
de Moerloose, P.4
-
17
-
-
27444434164
-
Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation
-
doi: 10.1016/j.jacc.2005.05.090
-
Tantry US, Bliden KP, Gurbel PA (2005) Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation. J Am Coll Cardiol 46:1705-1709. doi: 10.1016/ j.jacc.2005.05.090
-
(2005)
J Am Coll Cardiol
, vol.46
, pp. 1705-1709
-
-
Tantry, U.S.1
Bliden, K.P.2
Gurbel, P.A.3
-
18
-
-
38349092405
-
Testing aspirin resistance using the platelet function analyzer 100: Some methodological caveats and considerations
-
doi: 10.1111/j.1538-7836.2007.02850.x
-
Madsen EH, Schmidt EB, Gehr N, Johannesen NL, Kristensen SR (2008) Testing aspirin resistance using the platelet function analyzer 100: some methodological caveats and considerations. J Thromb Haemost 6:386-388. doi: 10.1111/j.1538-7836.2007.02850.x
-
(2008)
J Thromb Haemost
, vol.6
, pp. 386-388
-
-
Madsen, E.H.1
Schmidt, E.B.2
Gehr, N.3
Johannesen, N.L.4
Kristensen, S.R.5
-
19
-
-
0036826025
-
Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease
-
doi: 10.1016/S0049-3848(02)00405-X
-
Andersen K, Hurlen M, Arnesen H, Seljeflot I (2002) Aspirin non-responsiveness as measured by PFA-100 in patients with coronary artery disease. Thromb Res 108:37-42. doi: 10.1016/S0049-3848(02)00405-X
-
(2002)
Thromb Res
, vol.108
, pp. 37-42
-
-
Andersen, K.1
Hurlen, M.2
Arnesen, H.3
Seljeflot, I.4
-
20
-
-
0027970934
-
Development of aspirin resistance in persons with previous ischemic stroke
-
Helgason CM, Bolin KM, Hoff JA, Winkler SR, Mangat A, Tortorice KL, Brace LD (1994) Development of aspirin resistance in persons with previous ischemic stroke. Stroke 25:2331-2336
-
(1994)
Stroke
, vol.25
, pp. 2331-2336
-
-
Helgason, C.M.1
Bolin, K.M.2
Hoff, J.A.3
Winkler, S.R.4
Mangat, A.5
Tortorice, K.L.6
Brace, L.D.7
-
21
-
-
39749155679
-
Lack of reproducibility of assessment of aspirin responsiveness by optical aggregometry and two platelet function tests
-
doi: 10.1080/09537100701771736
-
Harrison P, Segal H, Silver L, Syed A, Cuthbertson FC, Rothwell PM (2008) Lack of reproducibility of assessment of aspirin responsiveness by optical aggregometry and two platelet function tests. Platelets 19:119-124. doi: 10.1080/09537100701771736
-
(2008)
Platelets
, vol.19
, pp. 119-124
-
-
Harrison, P.1
Segal, H.2
Silver, L.3
Syed, A.4
Cuthbertson, F.C.5
Rothwell, P.M.6
-
22
-
-
16844362580
-
Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarction
-
doi: 10.1016/j.amjcard.2004.12.038
-
Schwartz KA, Schwartz DE, Ghosheh K, Reeves MJ, Barber K, DeFranco A (2005) Compliance as a critical consideration in patients who appear to be resistant to aspirin after healing of myocardial infarction. Am J Cardiol 95:973-975. doi: 10.1016/j.amjcard.2004.12.038
-
(2005)
Am J Cardiol
, vol.95
, pp. 973-975
-
-
Schwartz, K.A.1
Schwartz, D.E.2
Ghosheh, K.3
Reeves, M.J.4
Barber, K.5
DeFranco, A.6
-
23
-
-
0035924765
-
Cyclooxigenase inhibitors and the antiplatelet effects of aspirin
-
doi: 10.1056/NEJMoa003199
-
Catella-Lawson F, Reilly MP, Kapoor SC, Cucchiara AJ, DeMarco S, Tournier B, Vyas SN, FitzGerald GA (2001) Cyclooxigenase inhibitors and the antiplatelet effects of aspirin. N Engl J Med 345:1809-1817. doi: 10.1056/NEJMoa003199
-
(2001)
N Engl J Med
, vol.345
, pp. 1809-1817
-
-
Catella-Lawson, F.1
Reilly, M.P.2
Kapoor, S.C.3
Cucchiara, A.J.4
DeMarco, S.5
Tournier, B.6
Vyas, S.N.7
FitzGerald, G.A.8
-
24
-
-
10744228434
-
Lack of aspirin effect: Aspirin resistance or resistance to taking aspirin?
-
doi: 10.1016/j.ahj.2003.07.011
-
Cotter G, Shemesh E, Zehavi M, Dinur I, Rudnick A, Milo O, Vered Z, Krakover R, Kaluski E, Kornberg A (2004) Lack of aspirin effect: Aspirin resistance or resistance to taking aspirin? Am Heart J 147:293-300. doi: 10.1016/j.ahj.2003.07.011
-
(2004)
Am Heart J
, vol.147
, pp. 293-300
-
-
Cotter, G.1
Shemesh, E.2
Zehavi, M.3
Dinur, I.4
Rudnick, A.5
Milo, O.6
Vered, Z.7
Krakover, R.8
Kaluski, E.9
Kornberg, A.10
-
25
-
-
34147120259
-
Indices of platelet activation and the stability of coronary artery disease
-
doi: 10.1111/j.1538-7836.2007.02462.x
-
Linden MD, Furman MI, Frelinger AL, Fox ML, Barnard MR, Li Y, Przyklenk K, Michelson AD (2007) Indices of platelet activation and the stability of coronary artery disease. J Thromb Haemost 5:761-765. doi: 10.1111/ j.1538-7836.2007.02462.x
-
(2007)
J Thromb Haemost
, vol.5
, pp. 761-765
-
-
Linden, M.D.1
Furman, M.I.2
Frelinger, A.L.3
Fox, M.L.4
Barnard, M.R.5
Li, Y.6
Przyklenk, K.7
Michelson, A.D.8
-
26
-
-
23244440960
-
Resistance to aspirin in patients after coronary artery bypass grafting is transient
-
doi: 10.1097/01.ftd.0000158084.84071.41
-
Golanski J, Chlopicki S, Gloanski R, Gresner P, Iwaszkiewicz A, Watala C (2005) Resistance to aspirin in patients after coronary artery bypass grafting is transient. Ther Drug Monit 27:484-490. doi: 10.1097/ 01.ftd.0000158084.84071.41
-
(2005)
Ther Drug Monit
, vol.27
, pp. 484-490
-
-
Golanski, J.1
Chlopicki, S.2
Gloanski, R.3
Gresner, P.4
Iwaszkiewicz, A.5
Watala, C.6
-
27
-
-
3543005314
-
Platelet inhibition by aspirin is diminished in patients during carotid surgery: A form of transient aspirin resistance?
-
Payne DA, Jones CI, Hayes PD, Webster SE, Naylor AR, Goodall AH (2004) Platelet inhibition by aspirin is diminished in patients during carotid surgery: A form of transient aspirin resistance? Thromb Haemost 92:89-96
-
(2004)
Thromb Haemost
, vol.92
, pp. 89-96
-
-
Payne, D.A.1
Jones, C.I.2
Hayes, P.D.3
Webster, S.E.4
Naylor, A.R.5
Goodall, A.H.6
-
28
-
-
34447503098
-
Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events
-
doi: 10.1001/archinte.167.15.1593
-
Snoep JD, Hovens MM, Eikenboom JC, van der Bom JG, Huisman MV (2007) Association of laboratory-defined aspirin resistance with a higher risk of recurrent cardiovascular events. Arch Intern Med 167:1593-1599. doi: 10.1001/archinte.167.15.1593
-
(2007)
Arch Intern Med
, vol.167
, pp. 1593-1599
-
-
Snoep, J.D.1
Hovens, M.M.2
Eikenboom, J.C.3
van der Bom, J.G.4
Huisman, M.V.5
-
29
-
-
38949119325
-
Aspirin "resistance" and risk of cardiovascular morbidity: Systemic review and meta-analysis
-
doi: 10.1136/bmj.39430.529549.BE
-
Krasopoulos G, Brister SJ, Beattie WS, Elliot RF, Buchanan MR (2008) Aspirin "resistance" and risk of cardiovascular morbidity: systemic review and meta-analysis. BMJ 336:195-198. doi: 10.1136/ bmj.39430.529549.BE
-
(2008)
BMJ
, vol.336
, pp. 195-198
-
-
Krasopoulos, G.1
Brister, S.J.2
Beattie, W.S.3
Elliot, R.F.4
Buchanan, M.R.5
-
30
-
-
39549117350
-
Use of the PFA-100™ closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: A systematic review and meta-analysis
-
doi: 10.1111/j.1538-7836.2008.02897.x
-
Reny JL, de Moerlosse P, Dauzat M, Fontana P (2008) Use of the PFA-100™ closure time to predict cardiovascular events in aspirin-treated cardiovascular patients: A systematic review and meta-analysis. J Thromb Haemost 6:444-450. doi: 10.1111/ j.1538-7836.2008.02897.x
-
(2008)
J Thromb Haemost
, vol.6
, pp. 444-450
-
-
Reny, J.L.1
de Moerlosse, P.2
Dauzat, M.3
Fontana, P.4
-
31
-
-
34250703278
-
Resistance to antiplatelet drugs: Molecular mechanisms and laboratory detection
-
doi: 10.1111/j.1538-7836.2007.02498.x
-
Cattaneo M (2007) Resistance to antiplatelet drugs: Molecular mechanisms and laboratory detection. J Thromb Haemost 5(Suppl1):230-237. doi: 10.1111/j.1538-7836.2007.02498.x
-
(2007)
J Thromb Haemost
, vol.5
, Issue.SUPPL. 1
, pp. 230-237
-
-
Cattaneo, M.1
|